Last reviewed · How we verify
NCT03789825: LiverScreen
Population-based Study in Screening for Liver Fibrosis
trial in Liver Diseases in 30,000 participants. Completed in 7 January 2025.
7 November 2024
Quick facts
| Lead sponsor | Judit Pich Martínez |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30,000 |
| Start date | 19 March 2018 |
| Primary completion | 7 November 2024 |
| Estimated completion | 7 January 2025 |
| Sites | 45 locations across Denmark, France, Italy, Netherlands, Slovakia, United Kingdom, Germany, Croatia |
Conditions studied
- Liver Diseases — all drugs for Liver Diseases →
Sponsor
Judit Pich Martínez — full company profile →
Who can join
40 and older, any sex, with Liver Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study to assess the prevalence of significant liver fibrosis in general population using Transient Elastography
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Non-invasive diagnosis and staging of non-alcoholic fatty liver disease.
Kechagias S, Ekstedt M, Simonsson C, Nasr P. · · 2022 · cited 24× · PMID 35661987 · DOI 10.1007/s42000-022-00377-8 -
LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
Graupera I, Thiele M, Ma AT, Serra-Burriel M, et al · · 2022 · cited 23× · PMID 35854275 · DOI 10.1186/s12889-022-13724-6 -
A higher FIB-4 index is associated with an increased incidence of renal failure in the general population.
Schleicher EM, Gairing SJ, Galle PR, Weinmann-Menke J, et al · · 2022 · cited 16× · PMID 36194174 · DOI 10.1002/hep4.2104
Verify or expand the search:
- PubMed search for NCT03789825
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Diseases
Currently open trials in the same condition.
- NCT07400289 — Development of a FibroScan Liver Examination Using a Single Probe · NA · recruiting
- NCT07150624 — The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine · Phase 4 · recruiting
- NCT06871111 — The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial · Phase 1 · recruiting
- NCT06874296 — Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time · NA · recruiting
- NCT07053488 — CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection · Phase 1, PHASE2 · recruiting
Other Judit Pich Martínez trials
Trials by the same sponsor.
- NCT04492995 — Sentinel Node in Endometrial Cancer · Phase 2 · unknown
- NCT04416906 — A Test and Treat Strategy in New HIV Diagnosis. · Phase 3 · completed
- NCT04329650 — Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03789825 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Judit Pich Martínez
- Last refreshed: 17 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03789825.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing